Uploaded on Aug 2, 2023
If you are facing employment law or pharmacy law issues, you need to speak to a California pharmacy lawyer At the Marcarian Law Firm, we are ready to investigate
Statutory Changes in Pharmacy Law for 2023 - Marcarian Law Firm Resources
Statutory Changes in Pharmacy Law
Unless otherwise noted, these provisions take effect January 1, 2023.
Underline text is added language. Strikethrough text is deleted language.
Business and Professions Code
Section 688 of the Business and Professions Code is amended to read:
688.
(a) On and after January 1, 2022, a A health care practitioner authorized to issue a
prescription pursuant to Section 4040 shall have the capability to issue an electronic
data transmission prescription, as defined under Section 4040, on behalf of a patient
and to transmit that electronic data transmission prescription to a pharmacy selected
by the patient.
(b)(1) On and after January 1, 2022, a A pharmacy, pharmacist, or other practitioner
authorized under California law to dispense or furnish a prescription pursuant to
Section 4040 shall have the capability to receive an electronic data transmission
prescription on behalf of a patient.
(2) A pharmacy, pharmacist, or other practitioner authorized under California law to
dispense or furnish a prescription pursuant to Section 4040 shall not refuse to
dispense or furnish an electronic data transmission prescription solely because
the prescription was not submitted via, or is not compatible with, the proprietary
software of the pharmacy, pharmacist, or other dispensing practitioner.
(3) A pharmacy, pharmacist, or other practitioner authorized under California law to
dispense or furnish a prescription pursuant to Section 4040 may decline to
dispense or furnish an electronic data transmission prescription submitted via a
software that fails to meet any of the following:
(A) Adheres to the National Council for Prescription Drug Programs SCRIPT
standard, as modified from time to time.
(B) Complies with the prescription content requirements set forth in Section 4040.
(C) For a controlled substance prescription, complies with Parts 1300, 1304,
1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended
from time to time.
(D) Complies with the federal Health Insurance Portability and Accountability Act
of 1996, the California Confidentiality of Medical Information Act, or the
security and confidentiality requirements prescribed to by the pharmacy,
pharmacist, or other practitioner authorized pursuant to Section 4040.
(c) For a prescription for a controlled substance, as defined by Section 4021, generation
and transmission of the electronic data transmission prescription shall comply with
Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as
amended from time to time.
(d) On and after January 1, 2022, a A prescription prescribed by a health care
practitioner shall be issued as an electronic data transmission prescription. This
subdivision shall not apply to prescriptions issued pursuant to subdivision (e).
2023 Summary of Law Changes
12/9/2022 Page 1 of 34
(e) Subdivision (d) shall not apply to any of the following:
(1) The prescription is issued pursuant to Section 11159.2 of the Health and Safety
Code.
(2) An electronic data transmission prescription is not available unavailable due to a
temporary technological or electrical failure. For purposes of this paragraph,
“temporary technological or electrical failure” means failure of a computer
system, application, or device, or the loss of electrical power to that system,
application, or device, or any other service interruption affecting the certified
electronic data transmission prescription application used to transmit the
prescription.
(3) The prescribing health care practitioner is issuing a prescription to be dispensed
by a pharmacy located outside California.
(4)(A) The prescription is issued in a hospital emergency department or urgent care
clinic and one or more of the following conditions are present:
(i) The patient resides outside California.
(ii) The patient resides outside the geographic area of the hospital.
(iii) The patient is homeless or indigent and does not have a preferred
pharmacy.
(iv) The prescription is issued at a time when a patient’s regular or preferred
pharmacy is likely to be closed.
(B) Under any of the conditions described in subparagraph (A), a prescription
shall be electronically issued but does not require electronic transmission and
may be provided directly to the patient.
(5) The prescription is issued by a veterinarian.
(6) The prescription is for eyeglasses or contact lenses.
(7) The prescription is issued by a prescribing health care practitioner and the
dispenser are the same entity. serving as a volunteer in a free clinic and receives
no remuneration for their services.
(8) The prescribing health care practitioner and the dispenser are the same entity.
(8)(9) The prescription is issued by a prescribing health care practitioner under
circumstances whereby the practitioner reasonably determines that it would be
impractical for the patient to obtain substances prescribed by an electronic data
transmission prescription in a timely manner, and the delay would adversely
impact the patient’s medical condition.
(9)(10) The prescription that is issued includes elements not covered by the latest
version of the National Council for Prescription Drug Programs’ SCRIPT
standard, as amended from time to time.
(11)(A) The prescriber registers with the California State Board of Pharmacy in a
manner and format determined by the board, stating that they meet one or more of
the following criteria:
(i) Their practice is located in the area of an emergency or disaster declared by a
federal, state, or local government.
(ii) They issue 100 or fewer prescriptions per calendar year.
(iii) They are unable to issue electronic data transmission prescriptions due to
circumstances beyond their control.
2023 Summary of Law Changes
12/9/2022 Page 2 of 34
(B) The prescriber shall annually submit the registration required in subparagraph
(A) to the California State Board of Pharmacy and maintain documentation of the
circumstances qualifying them for exemption under subparagraph (A).
(C) The California State Board of Pharmacy shall post a list of prescribers meeting
the requirements of subparagraph (A) on its internet website.
(f) A health care practitioner who issues a prescription for a controlled substance but
does not transmit the prescription as an electronic data transmission prescription
shall document the reason in the patient’s medical record as soon as practicable and
within 72 hours of the end of the technological or electrical failure that prevented the
electronic data transmission of the prescription.
(g)(1) A pharmacy that receives an electronic data transmission prescription from a
prescribing health care practitioner who has issued the prescription but has not
dispensed the medication to the patient shall, at the request of the patient or a
person authorized to make a request on behalf of the patient, immediately transfer or
forward the electronic data transmission prescription to an alternative pharmacy
designated by the requester. requester, unless one of the following applies:
(A) The action would result in a violation of any state or federal law.
(B) The action is not supported by the latest version of the National Council for
Prescription Drug Programs SCRIPT standard, as amended from time to
time.
(2) If a pharmacy is prohibited from transferring or forwarding electronic data
transmission prescriptions, as specified in paragraph (1), to a designated
alternative pharmacy, and that prohibition is subsequently removed, then that
pharmacy shall implement, within one year from the date the prohibition is
removed, the necessary provisions to allow for the transferring or forwarding of
an electronic data transmission prescription.
(h) If a pharmacy, or its staff, is aware than an attempted transmission of an electronic
data transmission prescription failed, is incomplete, or is otherwise not appropriately
received, the pharmacy shall immediately notify the prescribing health care
practitioner.
(i) A pharmacist who receives a written, oral, or faxed prescription shall not be required
to verify that the prescription properly falls under one of the exceptions in subdivision
(e). Pharmacists may continue to dispense medications from legally valid written,
oral, or fax prescriptions pursuant to this division.
(j) A health care practitioner, pharmacist, or pharmacy who fails to meet the applicable
requirements of this section shall be referred to the appropriate state professional
licensing board solely for administrative sanctions, as deemed appropriate by that
board. This section does not create a private right of action against a health care
practitioner. This section does not limit a health care practitioner’s liability for the
negligent failure to diagnose or treat a patient.
(k) This section shall not apply to a health care practitioner, pharmacist, or pharmacy
when providing health care services to an inmate, individual on parole, or youth
under the jurisdiction of the Department of Corrections and Rehabilitation.
2023 Summary of Law Changes
12/9/2022 Page 3 of 34
Section 1203.41 of the Penal Code is amended to read:
1203.41.
(a) If a defendant is sentenced pursuant to paragraph (5) of subdivision (h) of Section
1170, convicted of a felony, the court, in its discretion and in the interests of justice,
may order the following relief, subject to the conditions of subdivision (b):
(1) The court may permit the defendant to withdraw his or her their plea of guilty or
plea of nolo contendere and enter a plea of not guilty, or, if he or she the
defendant has been convicted after a plea of not guilty, the court shall set aside
the verdict of guilty, and, in either case, the court shall thereupon dismiss the
accusations or information against the defendant and he or she the
defendant shall thereafter be released from all penalties and disabilities resulting
from the offense of which he or she has they have been convicted, except as
provided in Section 13555 of the Vehicle Code.
(2) The relief available under this section may be granted only after the lapse of one
year following the defendant’s completion of the sentence, if the sentence was
imposed pursuant to subparagraph (B) of paragraph (5) of subdivision (h) of
Section 1170, or after the lapse of two years following the defendant’s completion
of the sentence, if the sentence was imposed pursuant to subparagraph (A) of
paragraph (5) of subdivision (h) of Section 1170.1170 or if the defendant was
sentenced to the state prison.
(3) The relief available under this section may be granted only if the defendant is
not on parole or under supervision pursuant to subparagraph (B) of paragraph (5)
of subdivision (h) of Section 1170, and is not serving a sentence for, on probation
for, or charged with the commission of any offense.
(4) The defendant shall be informed, either orally or in writing, of the provisions of
this section and of his or her their right, if any, to petition for a certificate of
rehabilitation and pardon at the time he or she is they are sentenced.
(5) The defendant may make the application and change of plea in person or by
attorney, or by a probation officer authorized in writing.
(6) If the defendant seeks relief under this section for a felony that resulted in a
sentence to the state prison, the relief available under this section may only be
granted if that felony did not result in a requirement to register as a sex offender
pursuant to Chapter 5.5 (commencing with Section 290) of Title 9 of Part 1.
(b) Relief granted pursuant to subdivision (a) is subject to all of the following conditions:
(1) In any subsequent prosecution of the defendant for any other offense, the prior
conviction may be pleaded and proved and shall have the same effect as if the
accusation or information had not been dismissed.
(2) The order shall state, and the defendant shall be informed, that the order does
not relieve him or her them of the obligation to disclose the conviction in
response to any direct question contained in any questionnaire or application for
public office, for licensure by any state or local agency, or agency or by a
2023 Summary of Law Changes
12/9/2022 Page 4 of 34
federally recognized tribe, or for contracting with the California State Lottery
Commission.
(3) Dismissal of an accusation or information pursuant to this section does not permit
a person to own, possess, or have in his or her their custody or control any
firearm or prevent his or her their conviction under Chapter 2 (commencing with
Section 29800) of Division 9 of Title 4 of Part 6.
(4) Dismissal of an accusation or information underlying a conviction pursuant to this
section does not permit a person prohibited from holding public office as a result
of that conviction to hold public office.
(c) This section applies to any conviction specified in subdivision (a) that occurred
before, on, or after January 1, 2014.2021.
(d) A person who petitions for a change of plea or setting aside of a verdict under this
section may be required to reimburse the court for the actual costs of services
rendered, whether or not the petition is granted and the records are sealed or
expunged, at a rate to be determined by the court not to exceed one hundred fifty
dollars ($150), and to reimburse the county for the actual costs of services rendered,
whether or not the petition is granted and the records are sealed or expunged, at a
rate to be determined by the county board of supervisors not to exceed one hundred
fifty dollars ($150), and to reimburse any city for the actual costs of services
rendered, whether or not the petition is granted and the records are sealed or
expunged, at a rate to be determined by the city council not to exceed one hundred
fifty dollars ($150). Ability to make this reimbursement shall be determined by the
court using the standards set forth in paragraph (2) of subdivision (g) of Section
987.8 and shall not be a prerequisite to a person’s eligibility under this section. The
court may order reimbursement in any case in which the petitioner appears to have
the ability to pay, without undue hardship, all or any portion of the costs for services
established pursuant to this subdivision.
(e)(1) Relief shall not be granted under this section unless the prosecuting attorney has
been given 15 days’ notice of the petition for relief. The probation officer shall notify
the prosecuting attorney when a petition is filed, pursuant to this section.
(2) It shall be presumed that the prosecuting attorney has received notice if proof of
service is filed with the court.
(f) If, after receiving notice pursuant to subdivision (e), the prosecuting attorney fails to
appear and object to a petition for dismissal, the prosecuting attorney may shall not
move to set aside or otherwise appeal the grant of that petition.
(g) Relief granted pursuant to this section does not release the defendant from the
terms and conditions of any unexpired criminal protective orders that have been
issued by the court pursuant to paragraph (1) of subdivision (i) of Section 136.2,
subdivision (j) of Section 273.5, subdivision (l) of Section 368, or subdivision (k) of
Section 646.9. These protective orders shall remain in full effect until expiration or
until any further order by the court modifying or terminating the order, despite the
dismissal of the underlying accusation or information.
2023 Summary of Law Changes
12/9/2022 Page 5 of 34
(h) Relief granted pursuant to this section does not affect the authority to receive, or
take adverse action based on, criminal history information, including the authority to
receive certified court records received or evaluated pursuant to Section 1522,
1568.09, 1569.17, or 1596.871 of the Health and Safety Code, or pursuant to any
statutory or regulatory provisions that incorporate the criteria of those sections.
Relief granted pursuant to this section does not make eligible a person who is
otherwise ineligible to provide, or receive payment for providing, in-home supportive
services pursuant to Article 7 (commencing with Section 12300) of Chapter 3 of Part
3 of Division 9 of the Welfare and Institutions Code, or pursuant to Section
14132.95, 14132.952, or 14132.956 of the Welfare and Institutions Code.
Section 1203.425 of the Penal Code is amended to read:
1203.425.
(a)(1)(A) Commencing July 1, 2022, and subject to an appropriation in the annual
Budget Act, on a monthly basis, the Department of Justice shall review the records
in the statewide criminal justice databases, and based on information in the state
summary criminal history repository and the Supervised Release File, shall identify
persons with convictions that meet the criteria set forth in subparagraph (B) and are
eligible for automatic conviction record relief.
(B) A person is eligible for automatic conviction relief pursuant to this section if
they meet all of the following conditions:
(i) The person is not required to register pursuant to the Sex Offender
Registration Act.
(ii) The person does not have an active record for local, state, or federal
supervision in the Supervised Release File.
(iii) Based upon the information available in the department’s record, including
disposition dates and sentencing terms, it does not appear that the person
is currently serving a sentence for an offense and there is no indication of
pending criminal charges.
(iv) Except as otherwise provided in subclause (III) of clause (v), there is no
indication that the conviction resulted in a sentence of incarceration in the
state prison.
(v) The conviction occurred on or after January 1, 1973, and meets either of
the following criteria:
(I) The defendant was sentenced to probation and, based upon the
disposition date and the term of probation specified in the department’s
records, appears to have completed their term of probation without
revocation.
(II) The defendant was convicted of an infraction or misdemeanor, was not
granted probation, and, based upon the disposition date and the term
specified in the department’s records, the defendant appears to have
2023 Summary of Law Changes
12/9/2022 Page 6 of 34
completed their sentence, and at least one calendar year has elapsed
since the date of judgment.
(2)(A) Except as specified in subdivision (b), the department shall grant relief,
including dismissal of a conviction, to a person identified pursuant to
paragraph (1) without requiring a petition or motion by a party for that relief if
the relevant information is present in the department’s electronic records.
(B) The state summary criminal history information shall include, directly next to
or below the entry or entries regarding the person’s criminal record, a note
stating “relief granted,” listing the date that the department granted relief and
this section. This note shall be included in all statewide criminal databases
with a record of the conviction.
(C) Except as otherwise provided in paragraph (4) and in Section 13555 of the
Vehicle Code, a person granted conviction relief pursuant to this section shall
be released from all penalties and disabilities resulting from the offense of
which the person has been convicted.
(3)(A) Commencing July 1, 2022, and subject to an appropriation in the annual
Budget Act, on a monthly basis, the department shall electronically submit a
notice to the superior court having jurisdiction over the criminal case,
informing the court of all cases for which a complaint was filed in that
jurisdiction and for which relief was granted pursuant to this section.
Commencing on January August 1, 2023, 2022, for any record retained by
the court pursuant to Section 68152 of the Government Code, except as
provided in paragraph (4), the court shall not disclose information concerning
a conviction granted relief pursuant to this section or Section 1203.4,
1203.4a, 1203.41, or 1203.42, to any person or entity, in any format, except
to the person whose conviction was granted relief or a criminal justice
agency, as defined in Section 851.92.
(B) If probation is transferred pursuant to Section 1203.9, the department shall
electronically submit a notice as provided in subparagraph (A) to both the
transferring court and any subsequent receiving court. The electronic notice
shall be in a mutually agreed upon format.
(C) If a receiving court reduces a felony to a misdemeanor pursuant to
subdivision (b) of Section 17, or dismisses a conviction pursuant to law,
including, but not limited to, Section 1203.4, 1203.4a, 1203.41, 1203.42,
1203.43, or 1203.49, it shall furnish a disposition report to the department
with the original case number and CII number from the transferring court. The
department shall electronically submit a notice to the superior court that
sentenced the defendant. If probation is transferred multiple times, the
department shall electronically submit a notice to all other involved courts.
The electronic notice shall be in a mutually agreed upon format.
(D) If a court receives notification from the department pursuant to subparagraph
(B), the court shall update its records to reflect the reduction or dismissal. If a
court receives notification that a case was dismissed pursuant to this section
2023 Summary of Law Changes
12/9/2022 Page 7 of 34
or Section 1203.4, 1203.4a, 1203.41, or 1203.42, the court shall update its
records to reflect the dismissal and shall not disclose information concerning
a conviction granted relief to any person or entity, in any format, except to the
person whose conviction was granted relief or a criminal justice agency, as
defined in Section 851.92.
(4) Relief granted pursuant to this section is subject to the following conditions:
(A) Relief granted pursuant to this section does not relieve a person of the
obligation to disclose a criminal conviction in response to a direct question
contained in a questionnaire or application for employment as a peace officer,
as defined in Section 830.
(B) Relief granted pursuant to this section does not relieve a person of the
obligation to disclose the conviction in response to a direct question contained
in a questionnaire or application for public office, or for contracting with the
California State Lottery Commission.
(C) Relief granted pursuant to this section has no effect on the ability of a
criminal justice agency, as defined in Section 851.92, to access and use
records that are granted relief to the same extent that would have been
permitted for a criminal justice agency had relief not been granted.
(D) Relief granted pursuant to this section does not limit the jurisdiction of the
court over a subsequently filed motion to amend the record, petition or motion
for postconviction relief, or collateral attack on a conviction for which relief has
been granted pursuant to this section.
(E) Relief granted pursuant to this section does not affect a person’s
authorization to own, possess, or have in the person’s custody or control a
firearm, or the person’s susceptibility to conviction under Chapter 2
(commencing with Section 29800) of Division 9 of Title 4 of Part 6, if the
criminal conviction would otherwise affect this authorization or susceptibility.
(F) Relief granted pursuant to this section does not affect a prohibition from
holding public office that would otherwise apply under law as a result of the
criminal conviction.
(G) Relief granted pursuant to this section does not release a person from the
terms and conditions of any unexpired criminal protective order that has been
issued by the court pursuant to paragraph (1) of subdivision (i) of Section
136.2, subdivision (j) of Section 273.5, subdivision (l) of Section 368, or
subdivision (k) of Section 646.9. These protective orders shall remain in full
effect until expiration or until any further order by the court modifying or
terminating the order, despite the dismissal of the underlying conviction.
(H) Relief granted pursuant to this section does not affect the authority to receive,
or take adverse action based on, criminal history information, including the
authority to receive certified court records received or evaluated pursuant to
Section 1522, 1568.09, 1569.17, or 1596.871 of the Health and Safety Code,
or pursuant to any statutory or regulatory provisions that incorporate the
criteria of those sections.
2023 Summary of Law Changes
12/9/2022 Page 8 of 34
(I) Relief granted pursuant to this section does not make eligible a person who is
otherwise ineligible to provide, or receive payment for providing, in-home
supportive services pursuant to Article 7 (commencing with Section 12300) of
Chapter 3 of Part 3 of Division 9 of the Welfare and Institutions Code, or
pursuant to Section 14132.95, 14132.952, or 14132.956 of the Welfare and
Institutions Code.
(J) In a subsequent prosecution of the defendant for any other offense, the prior
conviction may be pleaded and proved and shall have the same effect as if
the relief had not been granted.
(K)(i) Relief granted pursuant to this section does not affect the authority to
receive, or take adverse action based on, criminal history information,
including the authority to receive certified court records received or evaluated
pursuant to Article 1 (commencing with Section 44000) of Chapter 1, Article 3
(commencing with Section 44240) and Article 8 (commencing with Section
44330) of Chapter 2, Article 1 (commencing with Section 44420) of Chapter 3,
Article 3 (commencing with Section 44930) of Chapter 4, and Article 1
(commencing with Section 45100) and Article 6 (commencing with Section
45240) of Chapter 5, of Part 25 of Division 3 of Title 2 of the Education Code,
or pursuant to any statutory or regulatory provisions that relate to,
incorporate, expand upon, or interpret the authority of those provisions.
(ii) Notwithstanding clause (i) or any other law, information relating to a
conviction for a controlled substance offense listed in Section 11350 or
11377, or former Section 11500 or 11500.5, of the Health and Safety
Code that is more than five years old, for which relief is granted pursuant
to this section, shall not be disclosed.
(5) This section shall not limit petitions, motions, or orders for relief in a criminal
case, as required or authorized by any other law, including, but not limited to,
Sections 1203.4 and 1204.4a.
(6) Commencing July 1, 2022, and subject to an appropriation in the annual Budget
Act, the department shall annually publish statistics for each county regarding the
total number of convictions granted relief pursuant to this section and the total
number of convictions prohibited from automatic relief pursuant to subdivision
(b), on the OpenJustice Web portal, as defined in Section 13010.
(b)(1) The prosecuting attorney or probation department may, no later than 90 calendar
days before the date of a person’s eligibility for relief pursuant to this section, file a
petition to prohibit the department from granting automatic relief pursuant to this
section, based on a showing that granting that relief would pose a substantial threat
to the public safety. If probation was transferred pursuant to Section 1203.9, the
prosecuting attorney or probation department in either the receiving county or the
transferring county shall file the petition in the county of current jurisdiction.
(2) The court shall give notice to the defendant and conduct a hearing on the petition
within 45 days after the petition is filed.
2023 Summary of Law Changes
12/9/2022 Page 9 of 34
(3) At a hearing on the petition pursuant to this subdivision, the defendant, the
probation department, the prosecuting attorney, and the arresting agency,
through the prosecuting attorney, may present evidence to the court.
Notwithstanding Sections 1538.5 and 1539, the hearing may be heard and
determined upon declarations, affidavits, police investigative reports, copies of
state summary criminal history information and local summary criminal history
information, or any other evidence submitted by the parties that is material,
reliable, and relevant.
(4) The prosecutor or probation department has the initial burden of proof to show
that granting conviction relief would pose a substantial threat to the public safety.
In determining whether granting relief would pose a substantial threat to the
public safety, the court may consider any relevant factors including, but not
limited to, either of the following:
(A) Declarations or evidence regarding the offense for which a grant of relief is
being contested.
(B) The defendant’s record of arrests and convictions.
(5) If the court finds that the prosecutor or probation department has satisfied the
burden of proof, the burden shifts to the defendant to show that the hardship of
not obtaining relief outweighs the threat to the public safety of providing relief. In
determining whether the defendant’s hardship outweighs the threat to the public
safety, the court may consider any relevant factors including, but not limited to,
either of the following:
(A) The hardship to the defendant that has been caused by the conviction and
that would be caused if relief is not granted.
(B) Declarations or evidence regarding the defendant’s good character.
(6) If the court grants a petition pursuant to this subdivision, the court shall furnish a
disposition report to the Department of Justice pursuant to Section 13151, stating
that relief pursuant to this section was denied, and the department shall not grant
relief pursuant to this section. If probation was transferred pursuant to Section
1203.9, the department shall electronically submit a notice to the transferring
court, and, if probation was transferred multiple times, to all other involved courts.
(7) A person denied relief pursuant to this section may continue to be eligible for
relief pursuant to Section 1203.4 or 1203.4a. If the court subsequently grants
relief pursuant to one of those sections, the court shall furnish a disposition report
to the Department of Justice pursuant to Section 13151, stating that relief was
granted pursuant to the applicable section, and the department shall grant relief
pursuant to that section. If probation was transferred pursuant to Section 1203.9,
the department shall electronically submit a notice that relief was granted
pursuant to the applicable section to the transferring court and, if probation was
transferred multiple times, to all other involved courts.
(c) At the time of sentencing, the court shall advise a defendant, either orally or in
writing, of the provisions of this section and of the defendant’s right, if any, to petition
for a certificate of rehabilitation and pardon.
2023 Summary of Law Changes
12/9/2022 Page 10 of 34
(d) This section shall become inoperative on July 1, 2023, and, as of January 1, 2024, is
repealed.
Section 1203.425 is added to the Penal Code, to read:
1203.425.
(a)(1)(A) Commencing July 1, 2023, and subject to an appropriation in the annual
Budget Act, on a monthly basis, the Department of Justice shall review the records
in the statewide criminal justice databases, and based on information in the state
summary criminal history repository and the Supervised Release File, shall identify
persons with convictions that meet the criteria set forth in subparagraph (B) and are
eligible for automatic conviction record relief.
(B) A person is eligible for automatic conviction relief pursuant to this section if they
meet all of the following conditions:
(i) The person is not required to register pursuant to the Sex Offender
Registration Act.
(ii) The person does not have an active record for local, state, or federal
supervision in the Supervised Release File.
(iii) Based upon the information available in the department’s record, including
disposition dates and sentencing terms, it does not appear that the person is
currently serving a sentence for an offense and there is no indication of
pending criminal charges.
(iv) The conviction meets either of the following criteria:
(I) The conviction occurred on or after January 1, 1973, and meets either of
the following criteria:
(ia) The defendant was sentenced to probation and, based upon the
disposition date and the term of probation specified in the department’s
records, appears to have completed their term of probation without
revocation.
(ib) The defendant was convicted of an infraction or misdemeanor, was
not granted probation, and, based upon the disposition date and the
term specified in the department’s records, the defendant appears to
have completed their sentence, and at least one calendar year has
elapsed since the date of judgment.
(II) The conviction occurred on or after January 1, 2005, the defendant was
convicted of a felony other than one for which the defendant completed
probation without revocation, and based upon the disposition date and the
sentence specified in the department’s records, appears to have
completed all terms of incarceration, probation, mandatory supervision,
post release community supervision, and parole, and a period of four
years has elapsed since the date on which the defendant completed
probation or supervision for that conviction and during which the
defendant was not convicted of a new felony offense. This subclause does
2023 Summary of Law Changes
12/9/2022 Page 11 of 34
not apply to a conviction of a serious felony defined in subdivision (c) of
Section 1192.7, a violent felony as defined in Section 667.5, or a felony
offense requiring registration pursuant to Chapter 5.5 (commencing with
Section 290) of Title 9 of Part 1.
(2)(A) Except as specified in subdivision (b), the department shall grant relief,
including dismissal of a conviction, to a person identified pursuant to paragraph
(1) without requiring a petition or motion by a party for that relief if the relevant
information is present in the department’s electronic records.
(B) The state summary criminal history information shall include, directly next to
or below the entry or entries regarding the person’s criminal record, a note
stating “relief granted,” listing the date that the department granted relief and
this section. This note shall be included in all statewide criminal databases
with a record of the conviction.
(C) Except as otherwise provided in paragraph (4) and in Section 13555 of the
Vehicle Code, a person granted conviction relief pursuant to this section shall
be released from all penalties and disabilities resulting from the offense of
which the person has been convicted.
(3)(A) Commencing July 1, 2022, and subject to an appropriation in the annual
Budget Act, on a monthly basis, the department shall electronically submit a
notice to the superior court having jurisdiction over the criminal case, informing
the court of all cases for which a complaint was filed in that jurisdiction and for
which relief was granted pursuant to this section. Commencing on August 1,
2022, for any record retained by the court pursuant to Section 68152 of the
Government Code, except as provided in paragraph (4), the court shall not
disclose information concerning a conviction granted relief pursuant to this
section or Section 1203.4, 1203.4a, 1203.41, or 1203.42, to any person or entity,
in any format, except to the person whose conviction was granted relief or a
criminal justice agency, as defined in Section 851.92.
(B) If probation is transferred pursuant to Section 1203.9, the department shall
electronically submit a notice as provided in subparagraph (A) to both the
transferring court and any subsequent receiving court. The electronic notice
shall be in a mutually agreed upon format.
(C) If a receiving court reduces a felony to a misdemeanor pursuant to
subdivision (b) of Section 17, or dismisses a conviction pursuant to law,
including, but not limited to, Section 1203.4, 1203.4a, 1203.41, 1203.42,
1203.43, or 1203.49, it shall furnish a disposition report to the department
with the original case number and CII number from the transferring court. The
department shall electronically submit a notice to the superior court that
sentenced the defendant. If probation is transferred multiple times, the
department shall electronically submit a notice to all other involved courts.
The electronic notice shall be in a mutually agreed upon format.
(D) If a court receives notification from the department pursuant to subparagraph
(B), the court shall update its records to reflect the reduction or dismissal. If a
2023 Summary of Law Changes
12/9/2022 Page 12 of 34
court receives notification that a case was dismissed pursuant to this section
or Section 1203.4, 1203.4a, 1203.41, or 1203.42, the court shall update its
records to reflect the dismissal and shall not disclose information concerning
a conviction granted relief to any person or entity, in any format, except to the
person whose conviction was granted relief or a criminal justice agency, as
defined in Section 851.92.
(4) Relief granted pursuant to this section is subject to the following conditions:
(A) Relief granted pursuant to this section does not relieve a person of the
obligation to disclose a criminal conviction in response to a direct question
contained in a questionnaire or application for employment as a peace officer,
as defined in Section 830.
(B) Relief granted pursuant to this section does not relieve a person of the
obligation to disclose the conviction in response to a direct question contained
in a questionnaire or application for public office, or for contracting with the
California State Lottery Commission.
(C) Relief granted pursuant to this section has no effect on the ability of a
criminal justice agency, as defined in Section 851.92, to access and use
records that are granted relief to the same extent that would have been
permitted for a criminal justice agency had relief not been granted.
(D) Relief granted pursuant to this section does not limit the jurisdiction of the
court over a subsequently filed motion to amend the record, petition or motion
for postconviction relief, or collateral attack on a conviction for which relief has
been granted pursuant to this section.
(E) Relief granted pursuant to this section does not affect a person’s
authorization to own, possess, or have in the person’s custody or control a
firearm, or the person’s susceptibility to conviction under Chapter 2
(commencing with Section 29800) of Division 9 of Title 4 of Part 6, if the
criminal conviction would otherwise affect this authorization or susceptibility.
(F) Relief granted pursuant to this section does not affect a prohibition from
holding public office that would otherwise apply under law as a result of the
criminal conviction.
(G) Relief granted pursuant to this section does not release a person from the
terms and conditions of any unexpired criminal protective order that has been
issued by the court pursuant to paragraph (1) of subdivision (i) of Section
136.2, subdivision (j) of Section 273.5, subdivision (l) of Section 368, or
subdivision (k) of Section 646.9. These protective orders shall remain in full
effect until expiration or until any further order by the court modifying or
terminating the order, despite the dismissal of the underlying conviction.
(H) Relief granted pursuant to this section does not affect the authority to receive,
or take adverse action based on, criminal history information, including the
authority to receive certified court records received or evaluated pursuant to
Section 1522, 1568.09, 1569.17, or 1596.871 of the Health and Safety Code,
2023 Summary of Law Changes
12/9/2022 Page 13 of 34
or pursuant to any statutory or regulatory provisions that incorporate the
criteria of those sections.
(I) Relief granted pursuant to this section does not make eligible a person who is
otherwise ineligible to provide, or receive payment for providing, in-home
supportive services pursuant to Article 7 (commencing with Section 12300) of
Chapter 3 of Part 3 of Division 9 of the Welfare and Institutions Code, or
pursuant to Section 14132.95, 14132.952, or 14132.956 of the Welfare and
Institutions Code.
(J) In a subsequent prosecution of the defendant for any other offense, the prior
conviction may be pleaded and proved and shall have the same effect as if
the relief had not been granted.
(K)(i) Relief granted pursuant to this section does not affect the authority to
receive, or take adverse action based on, criminal history information,
including the authority to receive certified court records received or evaluated
pursuant to Article 1 (commencing with Section 44000) of Chapter 1, Article 3
(commencing with Section 44240) and Article 8 (commencing with Section
44330) of Chapter 2, Article 1 (commencing with Section 44420) of Chapter 3,
Article 3 (commencing with Section 44930) of Chapter 4, Article 1
(commencing with Section 45100) and Article 6 (commencing with Section
45240) of Chapter 5, of Part 25 of Division 3 of Title 2 of the Education Code,
or pursuant to any statutory or regulatory provisions that relate to,
incorporate, expand upon or interpret the authority of those provisions.
(ii) Notwithstanding clause (i) or any other law, information for a conviction for
a controlled substance offense listed in Section 11350 or 11377, or former
Section 11500 or 11500.5, of the Health and Safety Code that is more
than five years old, for which relief is granted pursuant to this section, shall
not be disclosed.
(L) Relief granted pursuant to this section does not release the defendant from
the terms and conditions of any unexpired criminal protective orders that have
been issued by the court pursuant to paragraph (1) of subdivision (i) of
Section 136.2, subdivision (j) of Section 273.5, subdivision (l) of Section 368,
or subdivision (k) of Section 646.9. These protective orders shall remain in full
effect until expiration or until any further order by the court modifying or
terminating the order, despite the dismissal of the underlying accusation or
information.
(5) This section shall not limit petitions, motions, or orders for relief in a criminal
case, as required or authorized by any other law, including, but not limited to,
Sections 1016.5, 1203.4, 1203.4a, 1203.4b, 1203.41, 1203.42, 1203.49, and
1473.7. This section shall not limit petitions for a certificate of rehabilitation or
pardon pursuant to Chapter 3.5 (commencing with Section 4852.01) of Title 6 of
Part 3.
(6) Commencing July 1, 2022, and subject to an appropriation in the annual Budget
Act, the department shall annually publish statistics for each county regarding the
2023 Summary of Law Changes
12/9/2022 Page 14 of 34
total number of convictions granted relief pursuant to this section and the total
number of convictions prohibited from automatic relief pursuant to subdivision
(b), on the Open Justice Web portal, as defined in Section 13010.
(b)(1) The prosecuting attorney or probation department may, no later than 90 calendar
days before the date of a person’s eligibility for relief pursuant to this section, file a
petition to prohibit the department from granting automatic relief pursuant to this
section, based on a showing that granting that relief would pose a substantial threat
to the public safety. If probation was transferred pursuant to Section 1203.9, the
prosecuting attorney or probation department in either the receiving county or the
transferring county shall file the petition in the county of current jurisdiction.
(2) The court shall give notice to the defendant and conduct a hearing on the petition
within 45 days after the petition is filed.
(3) At a hearing on the petition pursuant to this subdivision, the defendant, the
probation department, the prosecuting attorney, and the arresting agency,
through the prosecuting attorney, may present evidence to the court.
Notwithstanding Sections 1538.5 and 1539, the hearing may be heard and
determined upon declarations, affidavits, police investigative reports, copies of
state summary criminal history information and local summary criminal history
information, or any other evidence submitted by the parties that is material,
reliable, and relevant.
(4) The prosecutor or probation department has the initial burden of proof to show
that granting conviction relief would pose a substantial threat to the public safety.
In determining whether granting relief would pose a substantial threat to the
public safety, the court may consider any relevant factors including, but not
limited to, either of the following:
(A) Declarations or evidence regarding the offense for which a grant of relief is
being contested.
(B) The defendant’s record of arrests and convictions.
(5) If the court finds that the prosecutor or probation department has satisfied the
burden of proof, the burden shifts to the defendant to show that the hardship of
not obtaining relief outweighs the threat to the public safety of providing relief. In
determining whether the defendant’s hardship outweighs the threat to the public
safety, the court may consider any relevant factors including, but not limited to,
either of the following:
(A) The hardship to the defendant that has been caused by the conviction and
that would be caused if relief is not granted.
(B) Declarations or evidence regarding the defendant’s good character.
(6) If the court grants a petition pursuant to this subdivision, the court shall furnish a
disposition report to the Department of Justice pursuant to Section 13151, stating
that relief pursuant to this section was denied, and the department shall not grant
relief pursuant to this section. If probation was transferred pursuant to Section
1203.9, the department shall electronically submit a notice to the transferring
court, and, if probation was transferred multiple times, to all other involved courts.
2023 Summary of Law Changes
12/9/2022 Page 15 of 34
(7) A person denied relief pursuant to this section may continue to be eligible for
relief pursuant to law, including, but not limited to, Section 1203.4, 1203.4a,
1203.4b, or 1203.41. If the court subsequently grants relief pursuant to one of
those sections, the court shall furnish a disposition report to the Department of
Justice pursuant to Section 13151, stating that relief was granted pursuant to the
applicable section, and the department shall grant relief pursuant to that section.
If probation was transferred pursuant to Section 1203.9, the department shall
electronically submit a notice that relief was granted pursuant to the applicable
section to the transferring court and, if probation was transferred multiple times,
to all other involved courts.
(c) At the time of sentencing, the court shall advise a defendant, either orally or in
writing, of the provisions of this section and of the defendant’s right, if any, to petition
for a certificate of rehabilitation and pardon.
(d) This section shall become operative on July 1, 2023.
Section 4024 of the Business and Professions Code is amended to read:
4024.
(a) Except as provided in subdivision (b), “dispense” means the furnishing of drugs or
devices upon a prescription from a physician, nurse practitioner practicing pursuant
to Section 2837.103 or 2837.104, dentist, optometrist, podiatrist, veterinarian, or
naturopathic doctor pursuant to Section 3640.7, or upon an order to furnish drugs or
transmit a prescription from a certified nurse-midwife, nurse practitioner, practitioner
practicing pursuant to Section 2836.1, physician assistant, naturopathic doctor
pursuant to Section 3640.5, or pharmacist acting within the scope of his or
her their practice.
(b) “Dispense” also means and refers to the furnishing of drugs or devices directly to a
patient by a physician, nurse practitioner practicing pursuant to Section 2837.103 or
2837.104, dentist, optometrist, podiatrist, or veterinarian, or by a certified nurse-
midwife, nurse practitioner, practitioner practicing pursuant to Section
2836.1, naturopathic doctor, or physician assistant acting within the scope of his or
her their practice.
Section 4040 of the Business and Professions Code is amended to read:
4040.
(a) “Prescription” means an oral, written, or electronic transmission order that is both of
the following:
(1) Given individually for the person or persons for whom ordered that includes all of
the following:
(A) The name or names and address of the patient or patients.
(B) The name and quantity of the drug or device prescribed and the directions for
use.
(C) The date of issue.
2023 Summary of Law Changes
12/9/2022 Page 16 of 34
(D) Either rubber stamped, typed, or printed by hand or typeset, the name,
address, and telephone number of the prescriber, the prescriber’s license
classification, and the prescriber’s federal registry number, if a controlled
substance is prescribed.
(E) A legible, clear notice of the condition or purpose for which the drug is being
prescribed, if requested by the patient or patients.
(F) If in writing, signed by the prescriber issuing the order, or the certified nurse-
midwife, nurse practitioner, physician assistant, or naturopathic doctor who
issues a drug order pursuant to Section 2746.51, 2836.1, 3502.1, or 3640.5,
respectively, or the pharmacist who issues a drug order pursuant to Section
4052.1, 4052.2, or 4052.6.
(2) Issued by a physician, dentist, optometrist, doctor of podiatric medicine,
veterinarian, or nurse practitioner practicing pursuant to Section 2837.103 or
2837.104, or naturopathic doctor pursuant to Section 3640.7 or, if a drug order is
issued pursuant to Section 2746.51, 2836.1, 3502.1, or 3460.5, by a certified
nurse-midwife, nurse practitioner, physician assistant, or naturopathic doctor
licensed in this state, or pursuant to Section 4052.1, 4052.2, or 4052.6 by a
pharmacist licensed in this state.
(b) Notwithstanding subdivision (a), a written order of the prescriber for a dangerous
drug, except for any Schedule II controlled substance, that contains at least the
name and signature of the prescriber, the name and address of the patient in a
manner consistent with paragraph (2) of subdivision (a) of Section 11164 of the
Health and Safety Code, the name and quantity of the drug prescribed, directions for
use, and the date of issue may be treated as a prescription by the dispensing
pharmacist as long as any additional information required by subdivision (a) is
readily retrievable in the pharmacy. In the event of a conflict between this
subdivision and Section 11164 of the Health and Safety Code, Section 11164 of the
Health and Safety Code shall prevail.
(c) “Electronic transmission prescription” includes both image and data prescriptions.
“Electronic image transmission prescription” means any prescription order for which
a facsimile of the order is received by a pharmacy from a licensed prescriber.
“Electronic data transmission prescription” means any prescription order, other than
an electronic image transmission prescription, that is electronically transmitted from
a licensed prescriber to a pharmacy.
(d) The use of commonly used abbreviations shall not invalidate an otherwise valid
prescription.
Section 4052.01 of the Business and Professions Code is amended to read:
4052.01.
(a) Notwithstanding any other provision of law, a pharmacist may furnish naloxone
hydrochloride federal Food and Drug Administration-approved opioid antagonist in
accordance with standardized procedures or protocols developed and approved by
both the board and the Medical Board of California, in consultation with the
California Society of Addiction Medicine, the California Pharmacists Association, and
2023 Summary of Law Changes
12/9/2022 Page 17 of 34
other appropriate entities. In developing those standardized procedures or protocols,
the board and the Medical Board of California shall include the following:
(1) Procedures to ensure education of the person to whom the drug is furnished,
including, but not limited to, opioid overdose prevention, recognition, and
response, safe administration of naloxone hydrochloride, opioid antagonists,
potential side effects or adverse events, and the imperative to seek emergency
medical care for the patient.
(2) Procedures to ensure the education of the person to whom the drug is furnished
regarding the availability of drug treatment programs.
(3) Procedures for the notification of the patient’s primary care provider with patient
consent of any drugs or devices furnished to the patient, or entry of appropriate
information in a patient record system shared with the primary care provider, as
permitted by that primary care provider, and with patient consent.
(b) A pharmacist furnishing naloxone hydrochloride an opioid antagonist pursuant to this
section shall not permit the person to whom the drug is furnished to waive the
consultation required by the board and the Medical Board of California.
(c) Prior to performing a procedure authorized under this section, a pharmacist shall
complete a training program on the use of opioid antagonists that consists of at least
one hour of approved continuing education on the use of naloxone
hydrochloride. opioid antagonists.
(d) The board and the Medical Board of California are each authorized to ensure
compliance with this section. Each board is specifically charged with enforcing this
section with respect to its respective licensees. This section does not expand the
authority of a pharmacist to prescribe any prescription medication.
(e) The board may adopt emergency regulations to establish the standardized
procedures or protocols. The adoption of regulations pursuant to this subdivision
shall be deemed to be an emergency and necessary for the immediate preservation
of the public peace, health, safety, or general welfare. The emergency regulations
authorized by this subdivision are exempt from review by the Office of Administrative
Law. The emergency regulations authorized by this subdivision shall be submitted to
the Office of Administrative Law for filing with the Secretary of State and shall remain
in effect until the earlier of 180 days following their effective date or the effective date
of regulations adopted pursuant to subdivision (a).
Section 4060 of the Business and Professions Code is amended to read:
4060.
A person shall not possess any controlled substance, except that furnished to a person
upon the prescription of a physician, dentist, podiatrist, optometrist, veterinarian, or nurse
practitioner practicing pursuant to Section 2837.103 or 2837.104, or naturopathic doctor
pursuant to Section 3640.7, or furnished pursuant to a drug order issued by a certified
nurse-midwife pursuant to Section 2746.51, a nurse practitioner practicing pursuant to
Section 2836.1, a physician assistant pursuant to Section 3502.1, a naturopathic doctor
pursuant to Section 3640.5, or a pharmacist pursuant to Section 4052.1, 4052.2, or
4052.6. This section does not apply to the possession of any controlled substance by a
manufacturer, wholesaler, third-party logistics provider, pharmacy, pharmacist,
2023 Summary of Law Changes
12/9/2022 Page 18 of 34
physician, podiatrist, dentist, optometrist, veterinarian, naturopathic doctor, certified
nurse-midwife, nurse practitioner, or physician assistant, if in stock in containers correctly
labeled with the name and address of the supplier or producer.
This section does not authorize a certified nurse-midwife, a nurse practitioner, practitioner
practicing pursuant to Section 2836.1, a physician assistant, or a naturopathic doctor, to
order his or her their own stock of dangerous drugs and devices.
Section 4061 of the Business and Professions Code is amended to read:
4061.
(a) No manufacturer’s sales representative shall distribute any dangerous drug or
dangerous device as a complimentary sample without the written request of a
physician, dentist, podiatrist, optometrist, veterinarian, or nurse practitioner
practicing pursuant to Section 2837.103 or 2837.104, or naturopathic doctor
pursuant to Section 3640.7. However, a certified nurse-midwife who functions
pursuant to a standardized procedure or protocol described in Section 2746.51, a
nurse practitioner who functions pursuant to a standardized procedure described in
Section 2836.1, or protocol, a physician assistant who functions pursuant to a
protocol described in Section 3502.1, or a naturopathic doctor who functions
pursuant to a standardized procedure or protocol described in Section 3640.5, may
sign for the request and receipt of complimentary samples of a dangerous drug or
dangerous device that has been identified in the standardized procedure, protocol,
or practice agreement. Standardized procedures, protocols, and practice
agreements shall include specific approval by a physician. A review process,
consistent with the requirements of Section 2725, 3502.1, or 3640.5, of the
complimentary samples requested and received by a nurse practitioner, practitioner
practicing pursuant to Section 2836.1, certified nurse-midwife, physician assistant, or
naturopathic doctor, shall be defined within the standardized procedure, protocol, or
practice agreement.
(b) Each written request shall contain the names and addresses of the supplier and the
requester, the name and quantity of the specific dangerous drug desired, the name
of the certified nurse-midwife, nurse practitioner, physician assistant, or naturopathic
doctor, if applicable, receiving the samples pursuant to this section, the date of
receipt, and the name and quantity of the dangerous drugs or dangerous devices
provided. These records shall be preserved by the supplier with the records required
by Section 4059.
(c) Nothing in this section is intended to expand the scope of practice of a certified
nurse-midwife, nurse practitioner, physician assistant, or naturopathic doctor.
Section 4110.5 is added to the Business and Professions Code, to read:
4110.5.
Notwithstanding any other provision of this article, a county, city and county, or special
hospital authority described in Chapter 5 (commencing with Section 101850) or Chapter
5.5 (commencing with Section 101852) of Part 4 of Division 101 of the Health and
2023 Summary of Law Changes
12/9/2022 Page 19 of 34
Safety Code may operate a mobile unit to provide prescription medication within its
jurisdiction to those individuals without fixed addresses, individuals living in county-
owned or city-and-county-owned housing facilities, and those enrolled in Medi-Cal plans
operated by the county or a city and county, a health district, or a joint powers authority
pursuant to Chapter 7 (commencing with Section 14000) or Chapter 8 (commencing
with Section 14200) of Part 3 of Division 9 of the Welfare and Institutions Code. The
mobile unit shall be operated as an extension of a pharmacy license held by the county,
city and county, or special hospital authority. The mobile unit may dispense prescription
medication pursuant to a valid prescription, including a prescription of a physician who
practices in the mobile unit, if the county, city and county, or special hospital authority
meets all of the following requirements:
(a) A licensed pharmacist is on the premises and the mobile unit is under the control
and management of a pharmacist while prescription medications are being
dispensed.
(b) All activities of the pharmacist, including the furnishing of medication by the
pharmacist, are consistent with Article 3 (commencing with Section 4050).
(c) If a physician is practicing in the mobile unit, all prescribing by the physician meets
the requirements of the Medical Practice Act (Chapter 5 (commencing with Section
2000)).
(d) The mobile unit does not carry or dispense controlled substances.
(e) Dangerous drugs shall not be left in the mobile unit during the hours that the mobile
unit is not in operation.
(f) At least 30 days prior to commencing operation of a mobile unit, a county, city and
county, or special hospital authority shall notify the board of its intention to operate a
mobile unit. Notice shall also be given to the board at least 30 days prior to
discontinuing operation of a mobile unit.
Section 4126.10 of the Business and Professions Code is amended to read:
4126.10.
(a) A pharmacy located in California may distribute compounded human drug
preparations interstate only if all of the following conditions are met:
(1) Between January 1 and March 31 of each year, the pharmacy reports all required
data for the previous calendar year into the Information Sharing Network
established by the National Association of Boards of Pharmacy in conjunction
with the United States Food and Drug Administration (FDA) to implement the
Memorandum of Understanding Addressing Certain Distributions of
Compounded Human Drug Products.
(2) On an annual basis, in connection with and as a condition of renewal of the
pharmacy’s license, the pharmacist-in-charge of the pharmacy certifies that the
reporting requirements of paragraph (1) have been satisfied.
(3) The pharmacy reports any adverse drug experience and product quality issue for
any compounded product to the board within 12 hours after the pharmacy
receives notice of the adverse drug experience or product quality issue.
(b) Information reported by the board to the FDA directly or through the Information
Sharing Network established by the National Association of Boards of Pharmacy in
2023 Summary of Law Changes
12/9/2022 Page 20 of 34
conjunction with the FDA to implement the Memorandum of Understanding
Addressing Certain Distributions of Compounded Human Drug Products shall not be
subject to public disclosure under the California Public Records Act (Chapter
3.5 (Division 10 (commencing with Section 6250) of Division 7 of 7920.000) of Title
1 of the Government Code).
Section 4170 of the Business and Professions Code is amended to read:
4170.
(a) No A prescriber shall not dispense drugs or dangerous devices to patients in his or
her the prescriber’s office or place of practice unless all of the following conditions
are met:
(1) The dangerous drugs or dangerous devices are dispensed to the prescriber’s
own patient, and the drugs or dangerous devices are not furnished by a nurse or
physician attendant.
(2) The dangerous drugs or dangerous devices are necessary in the treatment of the
condition for which the prescriber is attending the patient.
(3) The prescriber does not keep a pharmacy, open shop, or drugstore, advertised
or otherwise, for the retailing of dangerous drugs, dangerous devices, or poisons.
(4) The prescriber fulfills all of the labeling requirements imposed upon pharmacists
by Section 4076, all of the recordkeeping requirements of this chapter, and all of
the packaging requirements of good pharmaceutical practice, including the use of
childproof containers.
(5) The prescriber does not use a dispensing device unless he or she the
prescriber personally owns the device and the contents of the device, and
personally dispenses the dangerous drugs or dangerous devices to the patient
packaged, labeled, and recorded in accordance with paragraph (4).
(6) The prescriber, prior to before dispensing, offers to give a written prescription to
the patient that the patient may elect to have filled by the prescriber or by any
pharmacy.
(7) The prescriber provides the patient with written disclosure that the patient has a
choice between obtaining the prescription from the dispensing prescriber or
obtaining the prescription at a pharmacy of the patient’s choice.
(8) A certified nurse-midwife who functions pursuant to a standardized procedure or
protocol described in Section 2746.51, a nurse practitioner who functions
pursuant to a standardized procedure described in Section 2836.1, or protocol, a
physician assistant who functions pursuant to Section 3502.1, or a naturopathic
doctor who functions pursuant to Section 3640.5, may hand to a patient of the
supervising physician and surgeon a properly labeled prescription drug
prepackaged by a physician and surgeon, a manufacturer as defined in this
chapter, or a pharmacist.
(b) The Medical Board of California, the California State Board of Optometry, the
Bureau of Naturopathic Medicine, the Dental Board of California,
the California Podiatric Medical Board of Podiatric Medicine, California, the
Osteopathic Medical Board of California, the Board of Registered Nursing, the
Veterinary Medical Board, and the Physician Assistant Committee Board shall have
2023 Summary of Law Changes
12/9/2022 Page 21 of 34
authority with the California State Board of Pharmacy to ensure compliance with this
section, and those boards are specifically charged with the enforcement of this
chapter with respect to their respective licensees.
(c) “Prescriber,” as used in this section, means a person, who holds a physician’s and
surgeon’s certificate, a license to practice optometry, a license to practice
naturopathic medicine, a license to practice dentistry, a license to practice veterinary
medicine, a certificate to practice podiatry, or a certificate to practice podiatry, as a
nurse practitioner practicing pursuant to Section 2837.103 or 2837.104, and who is
duly registered by the Medical Board of California, the Osteopathic Medical Board of
California, the California State Board of Optometry, the Bureau of Naturopathic
Medicine, the Dental Board of California, the Veterinary Medical Board, the Podiatric
Medical Board of California, or the California Board of Podiatric
Medicine. Registered Nursing.
2023 Summary of Law Changes
12/9/2022 Page 22 of 34
Section 4174 of the Business and Professions Code is amended to read:
4174.
Notwithstanding any other law, a pharmacist may dispense drugs or devices upon the
drug order of a nurse practitioner functioning practicing pursuant to Section 2836.1
or 2836.1, 2837.103, or 2837.104, or a certified nurse-midwife functioning pursuant to
Section 2746.51, a drug order of a physician assistant functioning pursuant to Section
3502.1 or a naturopathic doctor functioning pursuant to Section 3640.5, or the order of a
pharmacist acting under Section 4052.1, 4052.2, 4052.3, or 4052.6.
Section 4175 of the Business and Professions Code is amended to read:
4175.
(a) The California State Board of Pharmacy shall promptly forward to the appropriate
licensing entity, including the Medical Board of California, the Veterinary Medical
Board, the Dental Board of California, the California State Board of Optometry, the
California Board of Podiatric Medicine, the Osteopathic Medical Board of California,
the Board of Registered Nursing, the Bureau of Naturopathic Medicine, or the
Physician Assistant Committee, Board, all complaints received related to dangerous
drugs or dangerous devices dispensed by a prescriber, certified nurse-midwife,
nurse practitioner, naturopathic doctor, or physician assistant pursuant to Section
4170.
(b) All complaints involving serious bodily injury due to dangerous drugs or dangerous
devices dispensed by prescribers, certified nurse-midwives, nurse practitioners,
naturopathic doctors, or physician assistants pursuant to Section 4170 shall be
handled by the Medical Board of California, the Dental Board of California, the
California State Board of Optometry, the California Board of Podiatric Medicine, the
Osteopathic Medical Board of California, the Bureau of Naturopathic Medicine, the
Board of Registered Nursing, the Veterinary Medical Board, or the Physician
Assistant Committee as a case of greatest potential harm to a patient.
Section 4202 of the Business and Professions Code is amended to read:
4202.
(a) The board may issue a pharmacy technician license to an individual if he or she the
applicant is a high school graduate or possesses a general educational development
certificate equivalent, and meets any one of the following requirements:
(1) Has obtained an associate’s degree in pharmacy technology.
(2) Has completed a course of training specified by the board.
(3) Has graduated from a school of pharmacy recognized by the board.
(4) Is certified by a pharmacy technician certifying organization offering a pharmacy
technician certification program accredited by the National Commission for
Certifying Agencies that is approved by the board.
(b) The board shall adopt regulations pursuant to this section for the licensure of
pharmacy technicians and for the specification of training courses as set out in
paragraph (2) of subdivision (a). Proof of the qualifications of any applicant for
2023 Summary of Law Changes
12/9/2022 Page 23 of 34
licensure as a pharmacy technician shall be made to the satisfaction of the board
and shall be substantiated by any evidence required by the board.
(c) The board shall conduct a criminal background check of the applicant to determine if
an applicant has committed acts that would constitute grounds for denial of
licensure, pursuant to this chapter or Chapter 2 (commencing with Section 480) of
Division 1.5.
(d) The board may suspend or revoke a license issued pursuant to this section on any
ground specified in Section 4301.
(e) Once an individual is licensed as a pharmacist, the pharmacy technician registration
is no longer valid and the pharmacy technician license shall be returned to the board
within 15 days.
(f) This section shall remain in effect only until January 1, 2024, and as of that date is
repealed.
Section 4202 is added to the Business and Professions Code, to read:
4202.
(a) The board may issue a pharmacy technician license to an individual if the applicant
is a high school graduate or possesses a general educational development
certificate equivalent, and meets any one of the following requirements:
(1) Has obtained an associate’s degree in pharmacy technology.
(2) Has completed a course of training specified by the board.
(3) Has graduated from a school of pharmacy recognized by the board.
(4) Is certified by a pharmacy technician certifying organization offering a pharmacy
technician certification program accredited by the National Commission for
Certifying Agencies that is approved by the board.
(b) The board shall adopt regulations pursuant to this section for the licensure of
pharmacy technicians and for the specification of training courses as set out in
paragraph (2) of subdivision (a). Proof of the qualifications of any applicant for
licensure as a pharmacy technician shall be made to the satisfaction of the board
and shall be substantiated by any evidence required by the board.
(c) The board shall conduct a criminal background check of the applicant to determine if
an applicant has committed acts that would constitute grounds for denial of
licensure, pursuant to this chapter or Chapter 2 (commencing with Section 480) of
Division 1.5.
(d) The board shall not renew a pharmacy technician license unless the applicant
submits proof satisfactory to the board that the applicant has successfully completed
at least one hour of participation in a cultural competency course, as defined in
Section 4231, during the two years preceding the application for renewal.
(e) The board may suspend or revoke a license issued pursuant to this section on any
ground specified in Section 4301.
(f) Once an individual is licensed as a pharmacist, the pharmacy technician registration
is no longer valid and the pharmacy technician license shall be returned to the board
within 15 days.
(g) This section shall become operative on January 1, 2024.
2023 Summary of Law Changes
12/9/2022 Page 24 of 34
Section 4231 of the Business and Professions Code is amended to read:
4231.
(a) The board shall not renew a pharmacist license unless the applicant submits proof
satisfactory to the board that he or she the applicant has successfully completed 30
hours of approved courses of continuing pharmacy education during the two years
preceding the application for renewal.
(b) Notwithstanding subdivision (a), the board shall not require completion of continuing
education for the first renewal of a pharmacist license.
(c) If an applicant for renewal of a pharmacist license submits the renewal application
and payment of the renewal fee but does not submit proof satisfactory to the board
that the licensee has completed 30 hours of continuing pharmacy education, the
board shall not renew the license and shall issue the applicant an inactive
pharmacist license. A licensee with an inactive pharmacist license issued pursuant
to this section may obtain an active pharmacist license by paying the renewal fees
due and submitting satisfactory proof to the board that the licensee has completed
30 hours of continuing pharmacy education.
(d) If, as part of an investigation or audit conducted by the board, a pharmacist fails to
provide documentation substantiating the completion of continuing education as
required in subdivision (a), the board shall cancel the active pharmacist license and
issue an inactive pharmacist license in its place. A licensee with an inactive
pharmacist license issued pursuant to this section may obtain an active pharmacist
license by paying the renewal fees due and submitting satisfactory proof to the
board that the licensee has completed 30 hours of continuing pharmacy education.
(e) This section shall remain in effect only until January 1, 2024, and as of that date is
repealed.
Section 4231 is added to the Business and Professions Code, to read:
4231.
(a) For purposes of this section, “cultural competency course” means a cultural
competency and humility course that meets the following criteria:
(1) The course focuses on patients who identify as lesbian, gay, bisexual,
transgender, gender nonconforming, or queer, or who question their sexual
orientation or gender identity and expression.
(2) The course is approved from an accreditation agency approved by the board.
(3) The course covers recognized health disparities faced by Black, Indigenous, and
people of color.
(4) The course contains elements demonstrating how sexual identity is directly
impacted through intersectionality.
(b) The board shall not renew a pharmacist license unless the applicant submits proof
satisfactory to the board that the applicant has successfully completed 30 hours of
approved courses of continuing pharmacy education, including at least one hour of
participation in a cultural competency course, during the two years preceding the
application for renewal.
2023 Summary of Law Changes
12/9/2022 Page 25 of 34
(c) Notwithstanding subdivision (b), the board shall not require completion of continuing
education for the first renewal of a pharmacist license.
(d) If an applicant for renewal of a pharmacist license submits the renewal application
and payment of the renewal fee but does not submit proof satisfactory to the board
that the licensee has completed 30 hours of continuing pharmacy education, the
board shall not renew the license and shall issue the applicant an inactive
pharmacist license. A licensee with an inactive pharmacist license issued pursuant
to this section may obtain an active pharmacist license by paying the renewal fees
due and submitting satisfactory proof to the board that the licensee has completed
30 hours of continuing pharmacy education.
(e) If, as part of an investigation or audit conducted by the board, a pharmacist fails to
provide documentation substantiating the completion of continuing education as
required in subdivision (b), the board shall cancel the active pharmacist license and
issue an inactive pharmacist license in its place. A licensee with an inactive
pharmacist license issued pursuant to this section may obtain an active pharmacist
license by paying the renewal fees due and submitting satisfactory proof to the
board that the licensee has completed 30 hours of continuing pharmacy education.
(f) This section shall become operative on January 1, 2024.
Health and Safety Code
Section 1649.1 of the Health and Safety Code is amended to read:
1649.1.
Unless the context requires otherwise, the following definitions shall apply to this
chapter:
(a) “Compassionate Use Act of 1996” means the initiative measure enacted by the
approval of Proposition 215 at the November 5, 1996, statewide general election
and found at Section 11362.5, and any amendments to that act.
(b)(1) Except as provided in paragraph (2), “health care facility” means a health facility
specified in subdivision (a), (c), (f), (i), or (n) of Section 1250.
(2) The meaning of “health care facility” shall not include a chemical dependency
recovery hospital or a state hospital. any of the following:
(A) A chemical dependency recovery hospital.
(B) A state hospital.
(C) An emergency department of a health care facility, as specified in subdivision
(a) of Section 1250, while the patient is receiving emergency services and
care.
(c) “Medicinal cannabis” means cannabis or a cannabis product used in compliance with
the Compassionate Use Act of 1996 and Article 2.5 (commencing with Section
11362.7) of Chapter 6 of Division 10.
(d) “Patient” means an individual who is terminally ill. “Patient” does not include an
individual receiving emergency services and care, as defined in Section 1317.1.
(e) “Terminally ill” means a medical condition resulting in a prognosis of life of one year
or less, if the disease follows its natural course.
2023 Summary of Law Changes
12/9/2022 Page 26 of 34
Section 1649.2 of the Health and Safety Code is amended to read:
1649.2.
(a) A health care facility shall permit patient use of medical cannabis and shall do all of
the following:
(1)(a) Prohibit smoking or vaping as methods to use medicinal cannabis.
(2)(b) Include the use of medicinal cannabis within the patient’s medical records.
(3)(c) Require a patient to provide a copy of the patient’s valid identification card, as
described in Section 11362.715, or a copy of that patient’s written documentation as
defined in Section 11362.7.
(d) Require a patient or a primary caregiver, as defined in Section 11362.7, to be
responsible for acquiring, retrieving, administering, and removing medicinal
cannabis.
(4)(e) Reasonably restrict the manner in which a patient stores and uses medicinal
cannabis, including requiring the medicinal Require medicinal cannabis to be
stored securely at all times in a locked container, to ensure the safety of other
patients, guests, and employees of the health care facility, compliance with other
state laws, and the safe operations of the health care facility. container in the
patient’s room, other designated area, or with the patient’s primary caregiver.
(f) Prohibit health care professionals and facility staff, including, but not limited to,
physicians, nurses, and pharmacists, from administering medicinal cannabis or
retrieving medicinal cannabis from storage.
(5)(g) Develop and disseminate written guidelines for the use and disposal of medicinal
cannabis within the health care facility pursuant to this chapter.
(b) This section does not apply to a patient receiving emergency services and care, as
defined in Section 1317.1, or to the emergency department of a health care facility,
as specified in subdivision (a) of Section 1250, while the patient is receiving
emergency services and care.
Section 1649.3 of the Health and Safety Code is repealed.
1649.3.
Notwithstanding the classification of medicinal cannabis as a Schedule I drug and any
other law, health facilities permitting patient use of medicinal cannabis shall comply with
drug and medication requirements applicable to Schedule II, III, and IV drugs and shall
be subject to enforcement actions by the State Department of Public Health.
Section 1649.3 is added to the Health and Safety Code, to read:
1649.3.
Upon discharge, all remaining medicinal cannabis shall be removed by the patient or
patient’s primary caregiver. If a patient cannot remove the medicinal cannabis and does
not have a primary caregiver that is available to remove the medicinal cannabis, the
2023 Summary of Law Changes
12/9/2022 Page 27 of 34
product shall be stored in a locked container until it is disposed of in accordance with
the health facility policy and procedure governing medicinal cannabis.
Section 1649.4 of the Health and Safety Code is amended to read:
1649.4.
This chapter does not require a health care facility to provide or furnish a patient with a
recommendation to use medicinal cannabis in compliance with the Compassionate Use
Act of 1996 and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division
10 or include medicinal cannabis in a patient’s discharge plan.
Section 1649.5 of the Health and Safety Code is amended to read:
1649.5.
(a) This chapter shall be enforced by the State Department of Public Health.
(a)(b) Compliance with this chapter shall not be a condition for
obtaining, retaining, retaining, or renewing a license as a health care facility.
(b)(c) This chapter does not reduce, expand, or otherwise modify the laws restricting the
cultivation, possession, distribution, or use of cannabis that may be otherwise
applicable, including, but not limited to, the Control, Regulate and Tax Adult Use of
Marijuana Act, an initiative measure enacted by the approval of Proposition 64 at the
November 8, 2016, statewide general election, and any amendments to that act.
Section 150202 of the Health and Safety Code is amended to read:
150202.
(a) Notwithstanding any other law, a donor organization is defined, for purposes of this
division, to refer to one of the following health and care facilities that may donate
centrally stored unused medications under a program established pursuant to this
division: facilities, hospitals, and entities that legally possess centrally stored,
unused medication:
(1) A licensed general acute care hospital, as defined in Section 1250.
(2) A licensed acute psychiatric hospital, as defined in Section 1250.
(3) A licensed skilled nursing facility, as defined in Section 1250, including a skilled
nursing facility designated as an institution for mental disease.
(4) A licensed intermediate care facility, as defined in Section 1250.
(5) A licensed intermediate care facility/developmentally disabled-habilitative facility,
as defined in Section 1250.
(6) A licensed intermediate care facility/developmentally disabled-nursing facility, as
defined in Section 1250.
(7) A licensed correctional treatment center, as defined in Section 1250.
(8) A licensed psychiatric health facility, as defined in Section 1250.2.
(9) A licensed chemical dependency recovery hospital, as defined in Section 1250.3.
2023 Summary of Law Changes
12/9/2022 Page 28 of 34
(10) A licensed residential care facility for the elderly, as defined in Section 1569.2,
with 16 or more residents.
(11) An approved mental health rehabilitation center, as described in Section 5675
of the Welfare and Institutions Code.
(12) An eligible entity, as defined in subdivision (b) of Section 150201.
(13) A juvenile facility, as described in Section 208.3 of the Welfare and Institutions
Code.
(14) A local detention facility, as described in Section 6031.4 of the Penal Code.
(15) A facility that is any of the following:
(A) Licensed by the State Department of Social Services.
(B) Licensed by the State Department of Public Health.
(C) Licensed by the State Department of Health Care Services.
(D) Licensed by or under the jurisdiction of the Department of Corrections and
Rehabilitation.
(E) Licensed by or under the jurisdiction of the Division of Juvenile Justice.
(16) A licensed home health agency, as defined in Section 1725.
(17) A licensed hospice agency, as defined in Section 1745.
(18) A licensed hospice facility, as defined in subdivision (n) of Section 1250.
(b) Medication donated by health and care facilities pursuant to subdivision (a) shall
meet the requirements of subdivisions (c) and (d) of Section 150204 and shall be
unexpired medication that would have otherwise been destroyed by the facility or
another appropriate entity.
(c) Medication eligible for donation by the health and care facilities pursuant to
subdivision (a) shall be directly delivered from the dispensing pharmacy, wholesaler
or manufacturer, to the health or care facility and subsequently centrally stored.
Centrally stored medication that originated from a patient or resident is not eligible
for donation under this division.
Section 150202.5 of the Health and Safety Code is amended to read:
150202.5.
Notwithstanding any other law, a pharmacy, licensed in California and not on probation
with the California State Board of Pharmacy, whose primary or sole type of pharmacy
practice type is limited to a skilled nursing facility, home health care, board and care, or
mail order, Pharmacy may donate unused, unexpired medication that meets the
requirements of subdivisions (c) and (d) of Section 150204, under a program
established pursuant to this division and that meets either of the following requirements:
(a) The medication was received directly from a manufacturer or wholesaler.
(b) The medication was returned from a health facility to the issuing pharmacy, in a
manner consistent with state and federal law.
2023 Summary of Law Changes
12/9/2022 Page 29 of 34
Section 150204.5 is added to the Health and Safety Code, to read:
150204.5.
(a)(1) A regional pilot program may be established in the Counties of Santa Clara and
San Mateo and the City and County of San Francisco to determine the feasibility and
benefits of implementing and maintaining a repository and distribution program. The
regional pilot program shall run until January 1, 2030.
(b) Participating pharmacies in the regional pilot program shall be owned or operated by
the Counties of Santa Clara or San Mateo or the City and County of San Francisco,
licensed in California, and not on probation with the California State Board of
Pharmacy.
(c)(1) Participants in the regional pilot program shall develop and implement their
programs in accordance with this division.
(2) While participating in the regional pilot program, participants shall continue to
meet all other legal responsibilities and requirements relating to pharmacy
services and comply with all relevant state and federal statutes when
administering their programs.
(d) Section 150204 shall not apply to a pilot program established pursuant to this
section and Section 150204.6
Section 150204.6 is added to the Health and Safety Code, to read:
150204.6.
(a)(1) A county specified in Section 150204.5 may establish, by an action of the county
board of supervisors or by an action of the public health officer of the county, as
directed by the county board of supervisors, a repository and distribution program for
purposes of this division. The county shall advise the California State Board of
Pharmacy within 30 days from the date it establishes a repository and distribution
program.
(2) Only an eligible entity, pursuant to Section 150201, may participate in this
program to dispense medication donated to the drug repository and distribution
program.
(3) An eligible entity that seeks to participate in the program shall inform the county
health department and the California State Board of Pharmacy in writing of its
intent to participate in the program. An eligible entity may not participate in the
program until it has received written or electronic documentation from the county
health department confirming that the department has received its notice of
intent.
(4)(A) A participating primary care clinic, as described in Section 150201, shall
disclose to the county health department the name of the licensed physician who
shall be accountable to the California State Board of Pharmacy for the clinic’s
program operations pursuant to this division. This physician shall be the
2023 Summary of Law Changes
12/9/2022 Page 30 of 34
professional director, as defined in subdivision (c) of Section 4182 of the
Business and Professions Code.
(B) The county board of supervisors or public health officer of the county shall,
upon request, make available to the California State Board of Pharmacy the
information in this division.
(5) The county board of supervisors, the public health officer of the county, and the
California State Board of Pharmacy may prohibit an eligible or participating entity
from participating in the program if the entity does not comply with the provisions
of the program, pursuant to this division. If the county board of supervisors, the
public health officer of the county, or the California State Board of Pharmacy
prohibits an eligible or participating entity from participating in the program, it
shall provide written notice to the prohibited entity within 15 days of making this
determination. The county board of supervisors, the public health officer of the
county, and the California State Board of Pharmacy shall each ensure that this
notice is also provided to the other two entities.
(b) A county that elects to establish a repository and distribution program pursuant to
this division shall establish written procedures for, at a minimum, all of the following:
(1) Establishing eligibility for medically indigent patients who may participate in the
program.
(2) Ensuring that patients eligible for the program shall not be charged for any
medications provided under the program.
(3) Developing a formulary of medications appropriate for the repository and
distribution program.
(4) Ensuring proper safety and management of any medications collected by and
maintained under the authority of a participating entity.
(5) Ensuring the privacy of individuals for whom the medication was originally
prescribed.
(c) Medication donated to the repository and distribution program or transferred
between participating entities shall comply with the requirements specified in this
division. Medication donated to the repository and distribution program shall meet all
of the following criteria:
(1) The medication shall not be a controlled substance.
(2) The medication shall not have been adulterated, misbranded, or stored under
conditions contrary to standards set by the United States Pharmacopoeia (USP)
or the product manufacturer.
(3) The medication shall not have been in the possession of a patient or any
individual member of the public, and in the case of medications donated by a
hospital, facility, or entity, as described in Section 150202, shall have been under
the control of a staff member of the health or care facility who is licensed in
California as a health care professional or has completed, at a minimum, the
training requirements specified in Section 1569.69.
(d)(1) Only medication that is donated in unopened, tamper-evident packaging or
modified unit dose containers that meet USP standards is eligible for donation to the
2023 Summary of Law Changes
12/9/2022 Page 31 of 34
repository and distribution program, provided lot numbers and expiration dates are
affixed. Medication donated in opened containers shall not be dispensed by the
repository and distribution program, and once identified, shall be quarantined
immediately and handled and disposed of in accordance with the Medical Waste
Management Act (Part 14 (commencing with Section 117600) of Division 104).
(2)(A) A medication that is the subject of a United States Food and Drug
Administration managed risk evaluation and mitigation strategy pursuant to
Section 355-1 of Title 21 of the United States Code shall not be donated if this
inventory transfer is prohibited by that strategy, or if the inventory transfer
requires prior authorization from the manufacturer of the medication.
(B) A medication that is the subject of a United States Food and Drug
Administration managed risk evaluation and mitigation strategy pursuant to
Section 355-1 of Title 21 of the United States Code, the donation of which is
not prohibited pursuant to subparagraph (A), shall be managed and
dispensed according to the requirements of that strategy.
(e) A pharmacist or physician at a participating entity shall use their professional
judgment in determining whether donated medication meets the standards of this
division before accepting or dispensing medication under the repository and
distribution program.
(f) A pharmacist or physician shall adhere to standard pharmacy practices, as required
by state and federal law, when dispensing all medications.
(g) Medication that is donated to the repository and distribution program shall be
handled in the following ways:
(1) Dispensed to an eligible patient.
(2) Destroyed.
(3) Returned to a reverse distributor or licensed waste hauler.
(4) (A) Transferred to another participating entity within the county to be dispensed
to eligible patients pursuant to this division. Notwithstanding this paragraph, a
participating county-owned pharmacy may transfer eligible donated medication to
a participating county-owned pharmacy within another adjacent county that has
adopted a program pursuant to this division, if the pharmacies transferring the
medication have a written agreement between the entities that outlines protocols
and procedures for safe and appropriate drug transfer that are consistent with
this division.
(B) Medication donated under this division may be transferred more than once
only within the county and after the final transfer shall be dispensed to an
eligible patient, destroyed, or returned to a reverse distributor or licensed
waste hauler.
(C) Medication transferred pursuant to this paragraph shall be transferred with
documentation that identifies the drug name, strength, and quantity of the
medication, original manufacturer lot numbers, and current expiration date.
The document shall include a statement that the medication shall be handled
pursuant to subparagraph (B). A copy of this document shall be kept by the
2023 Summary of Law Changes
12/9/2022 Page 32 of 34
participating entity transferring the medication and the participating entity
receiving the medication.
(D) Medication donated from multiple facilities under this division may be
commingled by the participating entity. However, in the event of a recall,
recalled medication shall be destroyed at the National Drug Code level.
(E) Participating facilities shall maintain a system for recording and logging
donated medication which allows the tracking of medication in each
repackaged container back to the facility or facilities that donated the
medication.
(h) Medication that is donated to the repository and distribution program that does not
meet the requirements of this division shall not be distributed or transferred under
this program and shall be either destroyed or returned to a reverse distributor.
Donated medication that does not meet the requirements of this division shall not be
sold, dispensed, or otherwise transferred to any other entity.
(i)(1) When dispensed to an eligible patient under this program, the donated medication
shall be in a new, properly labeled container, specific to the eligible patient and
ensuring the privacy of the individuals for whom the medication was initially
dispensed. However, medications donated in sealed manufacturer’s packaging are
not required to be placed into a new container, but shall otherwise be appropriately
labeled. Expired medication shall not be dispensed.
(2) The pharmacy shall have repackaging policies and procedures in place for
identifying and recalling medications. Medication that is repackaged shall be
labeled with the earliest expiration date. Repackaged medication can only be
dispensed to patients within the county.
(j) A participating entity shall keep complete records of the acquisition and disposition of
medication donated to, and transferred, dispensed, and destroyed under, the
repository and distribution program. Notwithstanding any other law, the acquisition
record created by a participating entity may be used as the donation, destruction, or
disposition record required of a donor organization for donated medication.
(k) Local and county protocols established pursuant to this division shall conform to the
Pharmacy Law regarding packaging, transporting, storing, and dispensing all
medications.
(l) County protocols established for packaging, transporting, storing, and dispensing
medications that require refrigeration, including, but not limited to, a biological
product as defined in Section 351 of the federal Public Health Service Act (42 U.S.C.
Sec. 262), an intravenously injected drug, or an infused drug, shall include specific
procedures to ensure that these medications are packaged, transported, stored, and
dispensed at appropriate temperatures and in accordance with USP standards and
the Pharmacy Law.
(m) Notwithstanding any other law, a participating entity shall follow the same federal
and state procedural drug pedigree requirements for donated drugs as it would
follow for drugs purchased from a wholesaler or directly from a drug manufacturer.
2023 Summary of Law Changes
12/9/2022 Page 33 of 34
(n) On January 1, 2028, the Board of Pharmacy shall submit to the Legislature an
evaluation of the regional pilot programs and pilot participants’ compliance to
program requirements as specified in this division. The report shall comply with
Section 9795 of the Government Code.
(o) A participating entity shall disclose to the Board of Pharmacy any “medication
errors,” as that term is described in Section 1716 of Title 16 of the California Code of
Regulations, arising out of a program under this division, within 30 days of a
participating entity discovering the medication error.
(p) This section shall remain in effect only until January 1, 2030, and as of that date is
repealed.
Section 150205 of the Health and Safety Code is amended to read:
150205.
(a) The following persons and entities shall not be subject to criminal or civil liability for
injury caused when donating, accepting, or dispensing any entity or person donates,
accepts, or dispenses prescription drugs in compliance with this division:
(1) A prescription drug manufacturer, wholesaler, governmental entity, or
participating entity.
(2) A pharmacist or physician who accepts or dispenses prescription drugs.
(3) A licensed health or care facility, as described in Section 150202, or a pharmacy,
as described in Section 150202.5.
(b) A surplus medication collection and distribution intermediary, as described in Section
150208, shall not be subject to criminal or civil liability for injury caused when
facilitating the donation of medications to or transfer of medications in compliance
with this division.
2023 Summary of Law Changes
12/9/2022 Page 34 of 34
Comments